GlaxoSmithKline Pharmaceuticals Appoints Commercial Head - Oncology, Vinay Subramanian, to Leadership Team
GlaxoSmithKline Pharmaceuticals Ltd has announced the inclusion of Mr. Vinay Subramanian, Commercial Head - Oncology, to its senior management personnel. Mr. Subramanian is set to join the company’s leadership team, effective April 20, 2026, based out of Mumbai.The appointment marks a significant addition to the company’s executive structure.
Mr. Subramanian brings extensive experience spanning over 24 years across the Pharmaceuticals, Life Science, Healthcare Devices, and Medical Technology sectors.
In his professional career, Mr. Subramanian previously held prominent leadership positions at global firms, including Roche Products India Pvt ltd, GE Healthcare, Becton Dickinson & Company, and Pfizer.
Prior to his tenure at Roche, where he served as the India Enabling leader - Enterprise & Neighboring Countries, Mr. Subramanian was responsible for the immunotherapy portfolio and was part of the company’s leadership team. At GE, he focused on identifying and engaging business partners to establish new oncology centers and facilitated the creation of Cancer Care Centers (CCCs) and day care centers across India and the South Asia Region.
His experience includes consistently managing sales, business development, and key account management roles, achieving a track record of increasing revenue and expanding into new geographic markets.
Key Professional Details
| Detail | Description |
|---|---|
| Name | Mr. Vinay Subramanian |
| Designation | Commercial Head - Oncology |
| Date of Leadership Role | April 20, 2026 |
| Years of Experience | Over 24 years |
| Key Sectors | Pharmaceuticals, Life Science, Healthcare Devices, Medical Technology |
| Education | MBA in General Management (Annamalai University); Executive programs at Haas School of Business and GE Crotonville Leadership Academy. |
Mr. Subramanian received his bachelor's degree in science from the University of Mysore and further completed executive programs through the Berkeley Executive Program in Management.
GLAXO Stock Price Movement
Shares of GlaxoSmithKline Pharmaceuticals Limited are edging higher to ₹2443.5 as of 10:35 AM today, rallying 0.56% on the day. The pharmaceutical stock continues to trade in live market action, supported by a total volume of 6,548 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.